Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract OT1-16-01: A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2 positive breast cancer

Hyo S Han, Mary Disis, Robert Wesolowski, Carla Fisher, Shipra Gandhi, Nancy Chan, William Gwin, Keerthi Gogineni, Rosemarie Mick, Christina Sierra Rodriguez, Deanna Hogue, Hien Liu, Ricardo Costa, Brian Czerniecki

Cancer Res (2022) 82 (4_Supplement): OT1-16-01.

https://doi.org/10.1158/1538-7445.SABCS21-OT1-16-01

Published: 15 February 2022

View article titled, Abstract OT1-16-01: A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2 positive breast cancer

Journal Articles

Abstract OT2-18-01: Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer

Alexandra Torres, Carey Kokkonen, Mary Oladeji, Kurt D'Andrea, Rosemarie Mick, Vivek Narayan, Michael Mallamaci, Gayle Ewing, Hayley Knollman, Nadine M. Tung, Mark Robson, Katherine L. Nathanson, Susan Domchek, Payal D. Shah

Cancer Res (2022) 82 (4_Supplement): OT2-18-01.

https://doi.org/10.1158/1538-7445.SABCS21-OT2-18-01

Published: 15 February 2022

View article titled, Abstract OT2-18-01: Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer

Journal Articles

Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Cancer Res (2021) 81 (13_Supplement): CT005.

https://doi.org/10.1158/1538-7445.AM2021-CT005

Published: 01 July 2021

View article titled, Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Journal Articles

Abstract CT234: A Phase II, single arm study of maintenance rucaparib in patients with platinum-sensitive advanced pancreatic cancer and a pathogenic germline or somatic mutation in BRCA1, BRCA2 or PALB2

Kim A. Reiss Binder, Rosemarie Mick, Mark O'Hara, Ursina Teitelbaum, Thomas Karasic, Charles Schneider, Peter J. O'Dwyer, Erica Carpenter, Austin Pantel, Mehran Makvandi, David Mankoff, Katherine Nathanson, Kara Maxwell, Stacy Cowden, Mary Jane Fuhrer, Janae Romeo, Gregory L. Beatty, Susan Domchek

Cancer Res (2019) 79 (13_Supplement): CT234.

https://doi.org/10.1158/1538-7445.AM2019-CT234

Published: 01 July 2019

View article titled, Abstract CT234: A Phase II, single arm study of maintenance rucaparib in patients with platinum-sensitive advanced pancreatic cancer and a pathogenic germline or somatic mutation in BRCA1, BRCA2 or PALB2

Journal Articles

Abstract PR05: Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients

Cancer Res (2016) 76 (3_Supplement): PR05.

https://doi.org/10.1158/1538-7445.FBCR15-PR05

Published: 07 April 2016

View article titled, Abstract PR05: Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients

Journal Articles

Abstract CT137: Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma

David L. Bajor, Rosemarie Mick, Matthew J. Riese, Lee P. Richman, Xiaowei Xu, Drew A. Torigian, Erietta Stelekati, Martha Sweeney, Brendan Sullivan, Lynn M. Schuchter, Ravi Amaravadi, E. John Wherry, Robert H. Vonderheide

Cancer Res (2015) 75 (15_Supplement): CT137.

https://doi.org/10.1158/1538-7445.AM2015-CT137

Published: 01 August 2015

View article titled, Abstract CT137: Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma

Journal Articles

Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity

Cancer Res (2015) 75 (15_Supplement): 2858.

https://doi.org/10.1158/1538-7445.AM2015-2858

Published: 01 August 2015

View article titled, Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity

Journal Articles

Abstract 4333: Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC)

Saman Ahmed, Charu Aggarwal, Rosemarie Mick, Joshua Bauml, Roger Cohen, Stephan Kadauke, Trisha Sterlicchi, Tracey L. Evans, John C. Kucharczuk, Charu Desphande, Jennifer J D Morrissette, Robert Daber, Corey J. Langer

Cancer Res (2015) 75 (15_Supplement): 4333.

https://doi.org/10.1158/1538-7445.AM2015-4333

Published: 01 August 2015

View article titled, Abstract 4333: Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC)

Journal Articles

Abstract 2513: Molecular dissection of cell death mechanisms following ionizing radiation in vitro and in vivo

Meng Xu Welliver, Lori S. Hart, Jiangbin Ye, Chao Lu, Rosemarie Mick, Mei Kong, Dara Ditsworth, Anna Mesina, Fangping Zhao, Jennifer L. Guerriero, Weixing Zong, Constantinos Koumenis, Craig B. Thompson

Cancer Res (2011) 71 (8_Supplement): 2513.

https://doi.org/10.1158/1538-7445.AM2011-2513

Published: 15 April 2011

View article titled, Abstract 2513: Molecular dissection of cell death mechanisms following ionizing radiation in vitro and in vivo

Journal Articles

Thioredoxin Reductase-1 Mediates Curcumin-Induced Radiosensitization of Squamous Carcinoma Cells

Prashanthi Javvadi, Lauren Hertan, Rachelle Kosoff, Tatini Datta, Johann Kolev, Rosemarie Mick, Stephen W. Tuttle, Constantinos Koumenis

Cancer Res (2010) 70 (5): 1941–1950.

https://doi.org/10.1158/0008-5472.CAN-09-3025

Published: 28 February 2010

View article titled, Thioredoxin Reductase-1 Mediates Curcumin-Induced Radiosensitization of Squamous Carcinoma Cells

Includes: Supplementary data

Journal Articles

Targeted immunoediting her-2/neu phenotypes in early breast cancer: A new approach to cancer vaccines

Brian Czerniecki, Ursula Koldovsky, Shuwen Xu, Harvey Nisenbaum, Rosemarie Mick, Paul Zhang, Gary Koski

Cancer Res (2008) 68 (9_Supplement): LB-311.

Published: 01 May 2008

View article titled, Targeted immunoediting her-2/neu phenotypes in early breast cancer: A new approach to cancer vaccines

Journal Articles

Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance

Susan M. Domchek, Adri Recio, Rosemarie Mick, Carolyn E. Clark, Erica L. Carpenter, Kevin R. Fox, Angela DeMichele, Lynn M. Schuchter, Michael S. Leibowitz, Michael H. Wexler, Barbara A. Vance, Gregory L. Beatty, Elizabeth Veloso, Michael D. Feldman, Robert H. Vonderheide

Cancer Res (2007) 67 (21): 10546–10555.

https://doi.org/10.1158/0008-5472.CAN-07-2765

Published: 01 November 2007

View article titled, Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance

Includes: Supplementary data

Journal Articles

Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

Carolyn E. Clark, Sunil R. Hingorani, Rosemarie Mick, Chelsea Combs, David A. Tuveson, Robert H. Vonderheide

Cancer Res (2007) 67 (19): 9518–9527.

https://doi.org/10.1158/0008-5472.CAN-07-0175

Published: 01 October 2007

View article titled, Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

Includes: Supplementary data

Journal Articles

Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir

Zibin Jiang, Nabendu Pore, George J. Cerniglia, Rosemarie Mick, Maria-Magdelena Georgescu, Eric J. Bernhard, Stephen M. Hahn, Anjali K. Gupta, Amit Maity

Cancer Res (2007) 67 (9): 4467–4473.

https://doi.org/10.1158/0008-5472.CAN-06-3398

Published: 04 May 2007

View article titled, Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir

Journal Articles

Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

Cancer Res (2007) 67 (4): 1842–1852.

https://doi.org/10.1158/0008-5472.CAN-06-4038

Published: 16 February 2007

View article titled, Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

Includes: Supplementary data

Journal Articles

Type 1 polarized HER-2/neu pulsed dendritic cell vaccines generate anti-tumor CD8+ T cells despite the presence of antigen specific CD8 tolerance in patients with early non-invasive breast cancer

Shuwen Xu, Ursula Koldovsky, Rosemarie Mick, Harvey Nisenbaum, Daniel Wang, Paul Zhang, Brian J. Czerniecki

Cancer Res (2006) 66 (8_Supplement): 740–741.

Published: 15 April 2006

View article titled, Type 1 polarized HER-2/neu pulsed dendritic cell vaccines generate anti-tumor CD8+ T cells despite the presence of antigen specific CD8 tolerance in patients with early non-invasive breast cancer

Journal Articles

HIV Protease Inhibitors Block Akt Signaling and Radiosensitize Tumor Cells Both In vitro and In vivo

Anjali K. Gupta, George J. Cerniglia, Rosemarie Mick, W. Gillies McKenna, Ruth J. Muschel

Cancer Res (2005) 65 (18): 8256–8265.

https://doi.org/10.1158/0008-5472.CAN-05-1220

Published: 15 September 2005

View article titled, HIV Protease Inhibitors Block Akt Signaling and Radiosensitize Tumor Cells Both In vitro and In vivo

Journal Articles

The use of HIV protease inhibitors as radiosensitizers

Anjali K. Gupta, George J. Cerniglia, Rosemarie Mick, Ruth J. Muschel, W. Gillies McKenna

Cancer Res (2005) 65 (9_Supplement): 285.

Published: 01 May 2005

View article titled, The use of HIV protease inhibitors as radiosensitizers

Journal Articles

Interleukin-6 −174G→C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer

Angela DeMichele, Anne-Marie Martin, Rosemarie Mick, Priya Gor, Lisa Wray, Melissa Klein-Cabral, Galene Athanasiadis, Theresa Colligan, Edward Stadtmauer, Barbara Weber

Cancer Res (2003) 63 (22): 8051–8056.

Published: 21 November 2003

View article titled, Interleukin-6 −174G→C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer

Journal Articles

Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea

Elora Gupta, Timothy M. Lestingi, Rosemarie Mick, Jacqueline Ramirez, Everett E. Vokes, Mark J. Ratain

Cancer Res (1994) 54 (14): 3723–3725.

Published: 01 July 1994

View article titled, Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea

NARROW

Abstract OT1-16-01: A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2 positive breast cancer

Abstract OT2-18-01: Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer

Abstract CT005: T cell inflammation in the tumor microenvironment after agonist CD40 antibody: Clinical and translational results of a neoadjuvant clinical trial

Abstract CT234: A Phase II, single arm study of maintenance rucaparib in patients with platinum-sensitive advanced pancreatic cancer and a pathogenic germline or somatic mutation in BRCA1, BRCA2 or PALB2

Abstract PR05: Mechanisms of tumor response and resistance to radiation and dual checkpoint blockade in mice and patients

Abstract CT137: Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma

Abstract 2858: Radiation and dual immune checkpoint blockade overcome tumor resistance and distinctly improve immunity

Abstract 4333: Association of TP53 mutation status with clinical outcomes in patients with EGFR mutated non-small cell lung cancer (NSCLC)

Abstract 2513: Molecular dissection of cell death mechanisms following ionizing radiation in vitro and in vivo

Thioredoxin Reductase-1 Mediates Curcumin-Induced Radiosensitization of Squamous Carcinoma Cells

Targeted immunoediting her-2/neu phenotypes in early breast cancer: A new approach to cancer vaccines

Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance

Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion

Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir

Targeting HER-2/neu in Early Breast Cancer Development Using Dendritic Cells with Staged Interleukin-12 Burst Secretion

Type 1 polarized HER-2/neu pulsed dendritic cell vaccines generate anti-tumor CD8+ T cells despite the presence of antigen specific CD8 tolerance in patients with early non-invasive breast cancer

HIV Protease Inhibitors Block Akt Signaling and Radiosensitize Tumor Cells Both In vitro and In vivo

The use of HIV protease inhibitors as radiosensitizers

Interleukin-6 −174G→C Polymorphism Is Associated with Improved Outcome in High-Risk Breast Cancer

Metabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with Diarrhea

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only